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ITCIn this work, the behavior of the neurohypophyseal hormones and their selected analogs was studied in the
presence of membrane models in an attempt to correlate their activities with a distinct behavior at a level of
peptide–lipid interactions. The inﬂuence of the peptides studied on the lipid acyl chain order was determined
using FTIR spectroscopy. Conformational changes in the peptides upon binding to liposomes were examined
using CD spectra. Attempts were also made to determine the binding parameters of the peptides to lipids
using isothermal titration calorimetry (ITC). The results show unambiguously that the neurohyphophyseal
hormone-like peptides interact with lipids, being a model of a eukaryotic cell membrane. Moreover, hydro-
phobic interactions between the peptides and liposomes are likely to determine the overall conformation
of the peptide, especially below the temperature of the main phase transition (Tm). Thus, the bulky and hy-
drophobic nature of the residues incorporated into the N-terminal part of neurohyphophyseal hormones is an
important factor for both restriction of peptide mobility and the interaction of the analog with biomembrane.
In turn, above Tm, the electrostatic interactions become also relevant for the conformation of the acyclic tail of
the AVP-like peptides.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Arginine vasopressin (CYFQNCPRG-NH2, AVP) and oxytocin
(CYIQNCPLG-NH2, OT) belong to neurohypophyseal hormone family.
They are the C-terminal amidated nonapeptides with a disulﬁde
bridge between Cys residues at positions 1 and 6, which results in a
20-membered tocin ring and a linear tripeptidic tail. Both peptides
differ from each other with amino acids at positions 3 and 8, which trig-
gers considerable differences in their activity. Thus, vasopressin controls
ﬁrst of all urine concentration and the blood pressure [1–3]. Moreover,
it is responsible for the stimulation of the adrenocorticotropine secre-
tion [4] and stability of the body temperature [5]. In turn, oxytocin is
responsible most of all for the maintenance of labor and lactation. It
plays indirectly a facilitatory role in the preovulatory luteinizing hor-
mone (LH) surge. Moreover, recent studies have shown that both pep-
tides are probably involved in the memory and learning processes
as well as sexual and social behaviors [6–10]. These different biological
activities of AVP and OT are mediated by four receptor subtypes:, arginine vasopressin; cis-Apc,
gl, D-α-2-indanylglycine; DPC,
ero-3-phosphocholine; DPPG,
ine-2-carboxylic acid; GPCR, G
le; Mpa, 3-mercaptopropionic
-palmitoyl-2-oleoyl-sn-glycero-
-3-phosphoglycerol; SDS, sodi-
).
l rights reserved.V2 (renal), V1a (vasopressor), V1b (pituitary) and OT (uterine), being
typical members of class A GPCR, which are membrane-spanning pro-
teins [11–14]. The current model for peptide hormone interactions
with GPCR suggests that the bioactive conformation of the peptide is
induced upon association with the cell membrane followed by a two-
dimensional diffusion process, whereby the peptide is recognized and
then interacts with the receptor [15,16]. Upon membrane binding, the
ligand is structured and oriented in such a way that receptor coupling
is encouraged. Moreover, elevated local concentration of the peptide
at the cell surface is promoted, which additionally facilitates its docking
into receptor cavity [17,18]. Some peptides upon association with the
membrane tend to translocate across the membrane without apparent
effect in the lipid bilayer (CPPs, cell-penetrating peptides) [19] or are
likely disrupt its integrity, causing perturbation of cell homeostasis lead-
ing to cell death (AMPs, antimicrobial peptides) [20] (Fig. 1). Bearing
all this in mind, it is obvious that the pathway of peptide–membrane
interactions is closely related to the peptide structure and function.
In this work, the behavior of the neurohypophyseal hormones and
their selected analogswas studied in the presence ofmembranemodels
in an attempt to correlate their activities with a distinct behavior at the
level of peptide–lipid interactions. Phosphatidylcholine lipids were
employed to mimic a eukaryotic membrane. To mimic the electrostatic
properties of the plasma membrane characterized by a slight preva-
lence of a negative charge, a small amount of the phosphoglycerol lipids,
with negatively charged head groups was added. The inﬂuence of the
peptides on the lipid acyl chain ordering was determined using FTIR
spectroscopy. The conformational changes in the peptides upon binding
to liposomes were examined using CD spectra. Attempts were also
Fig. 2. General structure of the peptides studied (A) and the structures of D-α-2-
indanylglycine, D-Igl; (S)-2-(1-adamantyl)glycine, Adg and cis-1-amino-4-
phenylcyclohexane-1-carboxylic acid, cis-Apc (B).
Fig. 1. Peptide–membrane interaction patterns in relation to peptide function.
Modiﬁed from [19].
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using isothermal titration calorimetry (ITC). To the best of our
knowledge, this is the ﬁrst report on interactions between neurohy-
pophyseal hormone-like peptides and liposomes.
It has been known that replacement of the naturally occurring
Tyr2 in neurohypophyseal hormones, which is responsible for recep-
tor activation and signal transduction [21], with bulky and/or sterical-
ly restricted substituents is favorable for generation of effective
antagonists of OT and V1a receptors. Thus, the selected analogs were
modiﬁed at position 2 with bulky hydrophobic residues (Fig. 2): D-α-
2-indanylglycine (D-Igl), (S)-2-(1-adamantyl)glycine (Adg) and cis-1-
amino-4-phenylcyclohexane-1-carboxylic acid (cis-Apc) [22–24].
α-Indanylglycine is a Cβ-branched amino acid, and this type of residue
usually facilitates extended strand formation [25]. It has successfully
been applied for the synthesis of potent and totally enzyme-resistant
bradykinin antagonists [26]. In turn, the adamantyl amino acids are
usually γ-turn inducers for peptides [27]. To our knowledge, the
adamantane-derived unnatural amino acids were earlier used to modi-
fy the methionine-enkephalin analogs [28] and gramicidin S [29], to af-
ford peptides with interesting biological properties. In both cases,
incorporation of 2-(1-adamantyl)glycine resulted in stronger hydro-
phobic interactions with membranes, thus beneﬁting in a promising
candidate for development of new anticancer and antimicrobial agents,
respectively. The Cα–Cα cyclized residue (cis-Apc) is constrained to
adopt conformations in the 310/α-helical regions of the ϕ and ψ spaces.
Consequently, they can be accommodated in either i+1 position of
type III (III′) β-turns or in the i+2 position of type II (II′) β-turns
[30–32]. The studies in our laboratory have shown that such approach
could result in AVP analogs with very interesting pharmacological
properties [33–35].
The results of pharmacological evaluation of the analogs, together
with the relevant data for AVP and OT [36], are shown in Table 1. As
seen, the combination of the Adg modiﬁcation with inversion of
Table 1
Pharmacological properties of the peptides studied.
Analog Activities
Oxytocic uterus
in vitro no Mg2+
IU/mg (pA2)
Pressor IU/mg
(pA2)
Antidiuretic IU/mg
60 min (200 min)
I AVPa 17 412 465
II OTa 450 5 5
III [D-Igl2]AVPb pA2 ~8.20
~1.1 IU/mg
pA2 ~5.70 e
IV [Adg2,D-Arg8]VPc 0.20 0 b0.45 (b0.45)
V [cis-Apc2]OTd pA2 ~7.89±0.07 pA2 ~5.75 ND
e — Antidiuretic activity about 1000 times lower than AVP at the threshold level
(60 min) and about 10 times or more lower at the effect level 200 min; steeper dose
response curve; ND no data available.
a Values taken from ref. [36].
b Values taken from ref. [22].
c Values taken from ref. [24].
d Values taken from ref. [23].
2984 E. Sikorska et al. / Biochimica et Biophysica Acta 1818 (2012) 2982–2993Arg8 conﬁguration caused a dramatic decrease in peptide IV activity.
In turn, in the case of peptides III and V, the modiﬁcation with D-Igl
and cis-Apc, respectively, resulted in a weak antipressor and high
(III) or moderate (V) antioxytocic potency. However, analog III
changed its activity from antioxytocic to oxytocic with increasing of
concentration. These phenomena are likely to contribute to a slight
desensitization and down regulation of the receptor [37].
2. Materials and methods
2.1. Reagents
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-
dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoglycerol (POPG) and arginine vasopressin, AVP
(I), were purchased from Sigma-Aldrich, whereas oxytocin, OT (II),
was obtained from Bachem. The [D-Igl2]AVP (III), [Adg2,D-Arg8]VP
(IV) and [cis-Apc2]OT (V) analogs were synthesized manually by
solid-phase peptide synthesis using Fmoc [38] chemistry on polysty-
rene resin (Fmoc-Gly TentaGel S RAM, Rapp Polymere, 0.23 mmol/g)
on a 150-μmol scale. Details of the peptide synthesis have previously
been described [22–24].
2.2. Preparation of liposomes
Multilamellar vesicles (MLVs) consisting of DPPC and DPPG taken
at a 9:1 mole ratio were prepared by dissolving the lipids in a chloro-
form:methanol (2:1, v:v) mixture at a concentration of 3 mg/mL for
CD experiments, and at a concentration of 50 mg/mL for FTIR exper-
iments and evaporated under nitrogen ﬂow and desiccated under
vacuum overnight to remove any residual solvents. The dried ﬁlms
were then resuspended in either a 10 mM phosphate buffer, pH=
7.4 (FTIR) or distilled water (CD) with gentle vortex mixing for 2 h
at 45 °C (the temperature above the main phase transition point,
Tm=42 °C, for DPPC:DPPG at a mole ratio of 9:1 [39]). In the case
of peptide–lipid samples, lyophilized peptide was mixed with the
MLV suspension to obtain the desired peptide-to-lipid ratio and the
peptide–liposome mixture was incubated for 2 h at 45 °C. In the
next step, the samples were frozen and thawed for ﬁve cycles to re-
duce the liposome size and lamellarity. A single freeze–thaw cycle
consisted of freezing for 5 min at a dry ice temperature (−78 °C)
and subsequent thawing for 5 min in a water bath at 45 °C.
With the ITC measurements, POPC:POPG at a mole ratio of 9:1
were used as a simple model of eukaryotic membranes. The vesicles
made of POPC and POPG (phase transition point, Tm=−2 °C) remainin the liquid crystalline phase at room temperature [40]. Therefore,
after suspending in the 10 mM phosphate buffer, pH=7.4, the sam-
ples with POPC:POPG liposomes were vortexed for 2 h at room tem-
perature. The ﬁnal concentration of the lipids for ITC measurements
was 1 mM. Moreover, for the ITC measurements, large unilamellar
vesicles (LUVs) were prepared by extrusion (ten times) of the MLV
suspension through polycarbonate membranes (100 nm in diameter;
Whatman International Ltd.), using a mini-extruder (Avanti Polar
Lipids, Inc.).
2.3. FTIR measurements
The spectrawere recorded using amodel IFS66 Bruker infrared spec-
trometer equipped with a DTGS detector (Physicochemical Laborato-
ries, Faculty of Chemistry, University of Gdansk, Poland). Peptide–lipid
samples were placed between two CaF2 windows, which were separat-
ed by a 50-μm thick teﬂon spacer. The samples were thermostated by a
Haake C10 circulator (Gebrüder HAAKE GmbH, Karlsruhe, Germany).
Additionally, the temperature of the samples was controlled with a
CHY502 thermometer. The samples were examined over the 24–50 °C
temperature range. The temperature was equilibrated for 10 min after
each step. The spectra were recorded as average of 10 measurements,
each with 16 scans and the spectral resolution of 2 cm−1. For data pro-
cessing, the Bruker OPUS FT-IR software was used. A spectrum of the
10 mM phosphate buffer, pH=7.4, recorded at appropriate tempera-
ture was used as the reference and subtracted from the sample spectra.
The wavenumber position for the symmetric stretching CH2 mode was
determined using a multiple Gaussian curve ﬁtting procedure (Origin
7 software) in the region between 3000 and 2800 cm−1. Before ﬁtting,
the baseline was subtracted in the spectral region indicated. A second
derivative spectrum was used to determine the position of bands con-
tributing to the spectral interval. The results were plotted as a function
of temperature.
2.4. CD measurements
The CD spectra were recorded using peptide samples in an aque-
ous solution without and with the addition of the DPPC:DPPG (9:1,
mol:mol) liposomes. The CD measurements were carried out in water
instead of in phosphate buffer, because of strong interferences of the
latter below 200 nm. In spite of this, the pH of the samples, measured
just before starting the CD experiments, was 7.0 (uncorrected value).
The CD spectra were collected over the temperature range of 25 °C
to 45 °C at each 5 °C interval. The measurements were conducted on
0.1 mg/mL peptide solutions. A Jasco J-815 spectropolarimeter with a
2 cm/min scan speed was used (Physicochemical Laboratories, Faculty
of Chemistry, University of Gdansk, Poland). The spectra were recorded
separately over the ranges of 185–260 nm and 230–340 nm, with a
1 mmand 10 mmpath length, respectively. The spectra were corrected
by subtracting the background from the sample spectrum and plotted
as mean molar ellipticity Θ (degree×cm2×dmol−1) vs. wavelength λ
(nm). The signal/noise ratio was increased by acquiring each spectrum
over an average of three scans. The content of the secondary structure
was calculated from the spectra using a CONTINLL method [41].
2.5. ITC measurements
All ITC experiments were performed at 25 °C using an AutoITC iso-
thermal titration calorimeter (MicroCal Inc., Northampton, USA) with
a 1.4491-mL sample and reference cells. The reference cell was ﬁlled
with distilled water. The data, speciﬁcally the heat normalized per
mole of injectant, were processed with Origin 7 fromMicroCal. An ini-
tial 2-μL injection was discarded from each dataset in order to remove
the effect of titrant diffusion across the syringe tip during the equili-
bration process. The experiment consisted of injecting 10.02 μL (29
injections, 2 μL for the ﬁrst injection only) of a ca 1 mM solution of
Fig. 3. Evolution of the maximum frequency of the νs(CH2) stretching vibrations as a
function of temperature and their ﬁrst derivatives for DPPC:DPPG at a mole ratio of
9:1 in the absence and in the presence of the peptide. The peak maxima in the bottom
panels indicate the transition temperature. The concentration of phospholipids was
50 mg/mL. The lipid: peptide mole ratio was 10:1.
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containing the buffered (PBS, pH=7.4, 10 mM) ca 0.1 and 0.4 mMpep-
tide solution. A background titration was performed using identical
titrant with the buffer solution placed in the sample cell. The result
was subtracted from each experimental titration to account for the
heat of dilution. All the solutions were degassed before titrations. The
titrant was injected in 5 min intervals to ensure that the titration peak
returned to the baseline prior to the next injection. Each injection lasted
20 s. To ensure a homogeneous mixing in the cell, the stirrer speed
was kept constant at 300 rpm.
3. Results and discussion
3.1. FTIR
The frequencies of the asymmetric νas(CH2) and symmetric
νs(CH2) stretching bands of the methylene groups belonging to the
acyl chains of the phospholipids are convenient indicators of the
phase transition from the gel phase (Lβ′) to the liquid crystalline
(Lα) phase. It is known that the “melting” of the all-trans chains of
the phospholipids in the gel phase to the liquid-crystalline one in-
creases the number of gauche conformers. At the main phase transi-
tion point, the bilayer model contains equal percentages of ordered
and disordered phospholipids. The phase transition points are depen-
dent on the chemical nature of the model membrane constituents
[42–44].
The lipids undergo a highly cooperative chain melting phase tran-
sition, as indicated by an abrupt increase in the νas(CH2) and νs(CH2)
frequencies from the values around 2918 cm−1 and 2850 cm−1 at
the temperature below the transition point up to around 2922 cm−1
and 2852 cm−1 for asymmetric and symmetric stretching vibrations,
respectively, at a higher temperature. Fig. 3 displays an evolution of
the maximum frequency of the νs(CH2) as a function of temperature
for DPPC:DPPG at a mole ratio of 9:1, in the absence and in the pres-
ence of the peptides. The ﬁrst derivative of the curve was calculated
to detect more precisely the Tm of the lipids and lipid–peptide mix-
tures. The lipid:peptide mole ratio was 10:1.
The Tm of the DPPC:DPPG (9:1, mol:mol) was found at 41.4 °C,
which is consistent with that reported recently [39], and decreased
by 1.2–1.6 °C upon premixing with a peptide. The interactions of
peptide V induced a slight down-shift in the CH2 symmetric
stretching vibrations, below and above Tm. A slight down-shift in
stretching vibrations is usually explained by an increase in ordering
of the acyl chains. On the other hand, the interactions of the peptide
V with the hydrophobic core of the lipid membrane model lead to a
slight decrease in Tm indicating a less ordered packing of the acyl
chains of the lipid. Therefore, the decrease in wavenumber is proba-
bly due to an increase in interchain vibrational coupling caused by a
reduction of rotational disorder of the chains after peptide binding
[45]. With peptide IV, the peak positions of the symmetric stretching
band remained signiﬁcantly below those of the pure lipids at a tem-
perature above Tm, thus suggesting that the peptide suppressed
the membrane ﬂuidity only in the liquid crystalline phase.
3.2. The far-CD
The CD spectra recorded in the presence of lipid systems only pro-
vide a weighted average of themembrane-bound and free peptide con-
formations. In addition, the aromatic residues contribute to the far-UV
spectra, therefore the estimation of secondary structure is complicated.
Moreover, themethods used for analyzing the secondary structure con-
tent are calibrated to the globular proteins and should be applied with
caution to peptides. This notwithstanding, the circular dichroism is a
powerful method for the analysis of peptide conformational changes
upon interactions with model membranes [46,47].The far-CD spectra of the peptides studied in aqueous solution in
the absence and in the presence of the DPPC:DPPG (9:1, mol:mol) li-
posomes are shown in Figs. 4 and 5, respectively. As seen, the temper-
ature has only a slight inﬂuence on conformation of the peptides in
lipid-free solution. The CD spectra of vasopressin (AVP) and oxytocin
(OT) in water (Fig. 4) showmany similarities both in the number and
positions of the extremes. In both cases, the 200-nm region consti-
tutes of a pair of two negative bands, at 205 nm and 195 nm, which
are due to π–π* transition of the amide groups. The latter is also con-
tributed by the E1u transition of the aromatic group of tyrosine [48]. In
turn, the B1u band of phenylalanine transition, which lies at about
217 nm, is missing in the AVP spectrum. It was apparently hidden
by the more intense bands of other transitions lying in the same spec-
tral region [48].
A quantitative CD analysis (Fig. 6) reveals that the conformation of
the AVP and OT backbone is not signiﬁcantly inﬂuenced by the
change of solvent and temperature and remains in a mixture of an ex-
tended, turn and unordered structure under the experimental condi-
tions. Nevertheless, as a result of interactions with lipids (Fig. 5), the
band at 195 nm loses noticeably its intensity in both peptides. A clos-
er inspection of the complex band at 227 nm in the CD spectra in the
lipid-free solution, which is assigned to superposition of a positive
band of the amide n–π* transition and the aromatic B1u transition of
tyrosine [48], shows that it is noticeably stronger for vasopressin
than for oxytocin, which is consistent with earlier investigations
[48,49]. This is due to mutual arrangement of the aromatic side chains
of Tyr2 and Phe3, which according to NMR studies [50,51], are extend-
ed away from the center of the macrocyclic ring and are stacked face
Fig. 4. The temperature dependence of the far-CD spectra of the peptides in the lipid-free solution.
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the crystal structure of pressinoic acid [52]. The π–π interactions
certainly restrict conformational freedom of the tyrosine side chain
and stabilize its proper orientation, crucial for antidiuretic activity
[21]. In turn, with oxytocin, the tyrosine side chain is believed to lie
over the cyclic part of molecule, which is supposed to be important
for the oxytocic action [53]. The different behavior of the two native
peptides has also been noticed after their transferring from the lipid-
free aqueous solution to that with the DPPC:DPPG (9:1, mol:mol)liposomes. With vasopressin, a gradual decrease in intensity of the
complex band at 227 nm is observed over the range of 25 °C–45 °C,
this indicates that speciﬁc interactions of the aromatic nuclei of tyrosine
and phenylalanine areweakened in the presence of liposomes. A similar
effect has recently been observed upon transferring vasopressin to a
structure-stabilizing cosolvent, hexaﬂuoroacetone [54,55]. In turn,
with oxytocin, a slight increase in the 227 nm band ellipticity is noticed
upon binding of the peptide to liposome, with the largest change
occurring at 45 °C, i.e. above the temperature of main phase transition
Fig. 5. The temperature dependence of the far-CD spectra of the peptides in the presence of DPPC:DPPG (9:1, mol:mol) liposomes (3 mM in lipids).
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of OT is more exposed outside the molecule than in water.
With the remaining peptides studied, Tyr2 was replaced with bulky
hydrophobic residues. Consequently, the intensity of the negative
band at 195 nm, characteristic of the native peptides, and containing a
contribution from Tyr aromatic ring, has been suppressed. In addition,
the 227 nm band is slightly blue-shifted or/and it loses its intensity. In
the case of the peptide V, which has neither Tyr nor Phe, the 227 nm
band is missing.
A quantitative analysis of the CD spectra of the peptide III has
shown an increase in helical structure over the range from 25 °C
to 35 °C, while at a higher temperature, the percentage of individualsecondary structures seems to remain at the same level as in the
lipid-free solution (Fig. 6). The upper temperature (35 °C) is consis-
tent with the pretransition temperature of the DPPC:DPPGmembrane
at a mole ratio of 9:1 [39]. Bearing all this in mind, it is clear that the
structure of peptide III is dependent on the degree of the lipid alkyl
chains' disordering. On the other hand, the Tm of DPPC:DPPG (9:1,
mol:mol) in the presence of peptide III was found at 39.9 °C (see
the section FTIR). Thus, above this temperature, the choline groups
of the liposomes are folded inward towards the surface, exposing
more of the negatively charged phosphatidyl groups [56]. Thus, the pos-
sibility of electrostatic interactions between the positively charged Arg8
and negatively charged phosphatidyl groups is rising, which may affect
Fig. 6. The percentage of different secondary motifs in the peptides calculated on the basis of CD spectra under different conditions. The content of the secondary structure was
calculated from the CD spectra using a CONTINLL method.
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at 217 nm is undoubtedly due to the indanyl group of D-Igl2 π–π* tran-
sition [57], whereas the combination band at 223 nm is probably due
to both amide n–π* and aromatic high energy transitions π–π* of Phe.
By analogy with the native peptides, the changes of the ellipticity of
both shoulders in the 210–240 nm region upon binding to liposomes
identify the alteration of aromatic residue conformations and a change
of the backbone conformation in the N-terminal part of peptide III
[48]. It is worth noting that owing to the peptide III–lipid interactions,
the ellipticity of both shoulders in the 210–240 nm region, contributed
by aromatic π–π* transitions, increases in comparison to those in a
lipid-free solution. The same tendency was observed for the 227 nmband of oxytocin (vide supra). On the other hand, the ellipticity of both
shoulders decreases with an increase in the temperature, similar to
the 227 nm band of vasopressin. Nevertheless, in contrast to AVP,
they ﬁnally reach values close to those found for the peptide in the
lipid-free solution. This behavior may be due to the presence of the
D-enantiomer of the chromophore in position 2 of peptide III.
In the case of analogs IV and V, the CD spectra have an entirely dif-
ferent CD shape in pure water and in the water/liposome mixtures,
which indicates that both peptides interact with liposomes. The char-
acteristic feature of the CD spectra of both peptides in the DPPC:DPPG
solution is a negative extreme around 207 nm, which reﬂects the
presence of more ordered structures than in the lipid-free solution.
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increase of the helical structure content at the expense of the extend-
ed one, whereas the turn structure content has remained at the same
level under all the experimental conditions. Moreover, the conforma-
tion of the peptide V is independent of the temperature and hence
of the degree of hydrocarbon-chain disorder of the lipids.
In the case of the peptide IV, an increase in helical structure
percentage upon binding to the DPPC:DPPG liposomes is observed
only at 25 °C and 45 °C. In turn, over the range from 30 °C to 40 °C,
a slight increase in an extended structure is noticed, whereas the
helical structure content has remained at the same level as in the
lipid-free solution. The conformational changes of the lipid-boundFig. 7. The temperature dependence of the near-CD spectra of the peptides ipeptide IV at 45 °C is a consequence of the transition between the
ripple gel and lamellar liquid crystalline phases of the DPPC:DPPG
membrane. Moreover, by analogy to peptide III, an increase in the
temperature intensiﬁes the probability of electrostatic interactions
of D-Arg8 with more exposed negatively charged phospahtidyl groups
of liposomes. In turn, the temperature of 25 °C is not related to any
phase transitions. Therefore, the conformation of the membrane-
bound peptide IV seems to be controlled by factors other than the
membrane structure. The positive band at 223 nm in the CD spectra
of peptide IV in the lipid-free solution is associated with both the
B1u transition of the phenylalanine chromophore and the amide
n–π* transition. Its high ellipticity (~3000 deg×cm2×dmol−1) inn the lipid-free (left panel) and in the liposome solutions (right panel).
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tions between the aromatic side chain of Phe3 and the spatially-
extended Adg2. Upon binding of peptide IV to the liposome, the
223 nm band noticeably decreases, thus indicating changes of mutual
arrangement of both hydrophobic side chains.
3.3. The near-CD
Changes in the N-terminal part of OT upon binding to liposomes
are also conﬁrmed by the CD spectra in the long-wavelength region
(Fig. 7). With oxytocin in the lipid-free solution, the positive shoulder
or band around 250 nm can be assigned to the n–σ* transition of the
right-handed disulﬁde bond [49,58]. The negative band centered at
275 nm is due to a combination of the disulﬁde n–σ* and tyrosine
low energy π–π* transitions [59]. Upon raising the temperature, the
275 nm band decreases in magnitude, whereas that at 250 nm is
red-shifted and more clearly shaped with a maximum at 255 nm. In
addition, these changes are accompanied by the deepening of the
minimum at about 240 nm. Similar effects were previously observed
with decreasing solvent polarity [58]. In turn, in the presence of lipids,
an opposite temperature effect is produced. Thus, an increase in the
temperature results in the disappearance of both the 250 nm and
240 nm bands. This suggests that the disulﬁde bridge is rather exposed
to the polar aqueous phase than hidden in the hydrophobic part of lipo-
some.With vasopressin in the lipid-free solution, only a slight inﬂection
in the CD curve is observed at 255 nm, which completely disappears
after transfer of the peptide into the liposome solution.
The long-wavelength CD spectra of peptides III and IV in the
lipid-free aqueous solution exhibit the same extreme at 250 nm and
temperature dependence as that for OT. However, upon binding of
the peptides to liposomes, only the former still retains the similarities
to oxytocin, whereas the CD spectra of the latter are quite similar to
those of the lipid-bound AVP (data not shown). With peptide V, the
long-wavelength CD spectra in the lipid-free solution are clearly dif-
ferent from those of the remaining peptides. A broad positive band
centered around 260 nm (Fig. 7) is due to superposition of bothFig. 8. Isothermal titration of AVP with POPC:POPG (9:1, mol:mol) LUVs at 25 °C. The lower c
molar ratio (POPC:POPG (9:1)/peptide).the disulﬁde n–σ* and B2u aromatic (cis-Apc2) [60] transitions. After
transferring peptide V from the lipid-free solution into that with lipo-
somes, a band at 250 nm, assigned to disulﬁde transition, becomes
relatively well shaped. However, upon raising the temperature, it
red-shifts and becomes only a positive shoulder at 255 nm. In turn,
the contribution of the B2u aromatic (cis-Apc2) transition to the posi-
tive band at 240–270 seems to decrease upon binding to liposomes,
which indicates a change of the side chain arrangement. In our opin-
ion, the cis-Apc2 side chain penetrates into the hydrophobic part of
liposome.
3.4. ITC
Isothermal Titration Calorimetry (ITC) is a technique for monitor-
ing binding and is the method of choice for characterizing biomolec-
ular interactions. When two components are bound, heat is either
generated or absorbed. Measurement of this heat allows to accurately
determine binding constants, Kb, reaction stochiometry, n, enthalpy,
ΔH, and entropy, ΔS [61]. In the case of the peptides studied, the
small, constant, and exothermic heat ﬂows are due to simple dilution,
suggesting the absence of any incorporation of the peptides into the
lipid bilayer (Fig. 8). However, taking into account the fact that the
practical range of measurable binding constants by ITC is limited to
about 103–108 M−1 [61], the presented results suggest that either
the interactions are too weak to be measured by ITC or that the en-
thalpy change of the interactions is too low to be measured under ex-
perimental conditions. Indeed, a higher concentration of compounds
may lead to more informative binding isotherms if low binding afﬁn-
ity is expected. However, with the peptides studied, the choice of con-
centrations for the ITC experiments was limited by poor solubility of
peptides III–V in aqueous solution.
3.5. Biological relevance of peptide–membrane interactions
The conformational changes observed upon binding of the peptide
to liposomes indicate that the N-terminal part of the hormones playsurves represent the heat of reaction (measured by peak integration) as a function of the
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peptides from the lipid-free solution to that with DPPC:DPPG lipo-
somes affects most of all the arrangement of the aromatic side chains.
With vasopressin in aqueous solution, the Tyr2 and Phe3 side chains
have been found to be extended away from the 20-membered ring
system, and their mutual location is stabilized by a parallel π–π interac-
tions [50,51]. This arrangement reduces the contact of the hydrophobic
side chainswith thewatermolecules. As the result of AVP-lipid binding,
the stacking interactions between both aromatic residues are dimin-
ished, which is consistent with the results of our earlier studies [62].
Such a behavior suggests that both aromatic side chains are in the
less polar environment upon binding of the peptide to liposome and
they penetrate the hydrophobic liposome core. In the case of oxytocin,
Phe3 is replaced by Ile3, and the π–π stacking interactions cannot
occur. As a consequence, the Tyr2 side chainmay be rotated to a position
over the macrocyclic ring. However, our studies suggest that the Tyr2
side chain arrangement is slightly changed upon binding of OT to lipo-
somes. In our opinion, it is more exposed to the outside of the cyclic
part than in the lipid-free solution. This ﬁnding is supported by earlier
studies on interactions of OT with receptors [63]. Thus, in the OT–OTR
complex, such orientation of the Tyr2 side chain resulted in a strong
aromatic–aromatic interaction between the phenyl rings of Tyr2 and
nonconserved EL2 Phe185 of the receptor. This interaction can play a sig-
niﬁcant role in OT–OTR selectivity binding.
Due to different hydrophobicity proﬁles [64] of the AVP and
OT-like peptides (Fig. 9) in their acyclic part, also different interac-
tions of the C-terminus with liposomes can be expected. For the zwit-
terionic DPPC liposomes with only small negative charges due to the
presence of small amounts of DPPG (DPPC:DPPG, 9:1, mol:mol), the
hydrophobic interactions appear to be more effective in partitioning
of the peptides. However, as mentioned above, the possibility of the
electrostatic interactions between the positively charged C-terminal
part of AVP-like peptides and negatively charged phosphatidyl
groups of liposomes increases in the liquid crystalline phase. Never-
theless, with the peptides studied, the electrostatic interactions
seem to affect only the secondary structure of [D-Igl2]AVP (III) and
[Adg2,D-Arg8]VP (IV), whereas that of AVP remains practically
unchanged irrespective of the liposome arrangement. This ﬁnding is
consistent with our earlier NMR studies on AVP, which have suggested
that the positively charged Arg at position 8 of the vasopressin pro-
motes the same extended conformation of the C-terminus in both the
aqueous and the SDS micelle solutions [62].
Among the peptides studied, only the [Adg2,D-Arg8]VP (IV) ex-
hibits a negligible activity. At the same time, the FTIR results indicateFig. 9. The hydrophobicity proﬁles of AVP and OT. The proﬁles were created with the
Kyte and Doolitle scale using a ProtScale program online (http://web.expasy.org/
protscale/). Window size was set to 3.that it has a great impact on the membrane, changing its structure
above the main phase transition point. The same modiﬁcation used
in the tumor-cell-targeted enkephalin and antimicrobial gramicidin
S analogs, resulted in peptides displaying expected strong hydropho-
bic interactions with the membrane and increased transport through
the cell membrane [28,29]. With peptide IV, for which the interaction
with membrane is only an intermediate step on the way to the recep-
tor, the changes of the membrane structure around the receptor com-
plex induced by the peptide may negatively affect the ligand-binding
parameters of the receptor [65–68]. It seems reasonable, because
Gurdal et al. [69] found a correlation between the low membrane ﬂu-
idity and impaired coupling of the αs subunit with the β2-adrenergic
receptor.
4. Conclusions
The membrane-association of the peptide hormones is considered
to be an initial step in the peptide-receptor binding pathway. The hor-
mone receptors occupy only a small fraction of the total cell surface,
so that when a hormone molecule approaches a cell the ﬁrst contact is
much more likely to be realized with the lipid phase than with one of
its receptors [17].
In this work, by applying a combined approach of FTIR and CD
measurements, we were able to demonstrate that the neurohypophy-
seal hormone-like peptides interact with lipids, providing a model of
eukaryotic cell membrane. However, the interactions seem to be so
weak that the binding parameters are not measurable using the ITC
method. These results are consistent with ﬁndings that the peptides
do not penetrate across the membrane and that the peptide–lipid in-
teractions are not strong enough to destroy the cell membrane.
The results of our studies suggest that the hydrophobic interac-
tions between the peptides and DPPC:DPPG liposomes determine
the overall conformation of the peptide, especially below Tm. Above
the main phase transition temperature (Tm), the electrostatic interac-
tions become also relevant for the conformation of the acyclic tail of
the AVP-like peptides.
The bulky andhydrophobic residues incorporated into theN-terminal
part of neurohypophyseal hormones constitute an important factor for
both restriction of peptide mobility and the interaction of an analog
with biomembrane. However, the interactions with the membrane do
not guarantee the hormone activity. Indeed, introduction of a bulky
hydrophobic residue into neurohypophyseal hormone peptide se-
quences should facilitate the interaction with the hydrophobic core of
the biomembrane, but at the same time, it can produce an inactive ana-
log, because of difﬁculties with location of the “bulky” peptide inside
the not large enough receptor cavity.
The alterations in the lipid composition can affect physical proper-
ties of the bilayer including its curvature and ﬂuidity, while speciﬁc
interactions between its components and the peptide are likely to ap-
pear. Thus, membrane cholesterol has been reported to have a mod-
ulatory role in the function of a number of GPCRs. We believe that it
can also inﬂuence the peptide binding to the membrane. Therefore,
a more detailed knowledge of the surface potentials and lipid compo-
sition of the target cells will be necessary to elucidate the peptide
membrane-binding properties. Moreover, further studies are needed
to understand the relationship between biological function of the
neurohypophyseal hormone-like peptides, their conformation and
afﬁnity to the appropriate receptor.
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